nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—CYP2D6—Vinorelbine—ovarian cancer	0.0523	0.212	CbGbCtD
Mexiletine—CYP3A4—Topotecan—ovarian cancer	0.0472	0.192	CbGbCtD
Mexiletine—CYP2B6—Doxorubicin—ovarian cancer	0.041	0.166	CbGbCtD
Mexiletine—CYP3A4—Vinorelbine—ovarian cancer	0.0333	0.135	CbGbCtD
Mexiletine—CYP3A4—Paclitaxel—ovarian cancer	0.0234	0.0948	CbGbCtD
Mexiletine—CYP2D6—Doxorubicin—ovarian cancer	0.0198	0.0804	CbGbCtD
Mexiletine—CYP3A4—Docetaxel—ovarian cancer	0.0169	0.0686	CbGbCtD
Mexiletine—CYP3A4—Doxorubicin—ovarian cancer	0.0126	0.0511	CbGbCtD
Mexiletine—AHR—myometrium—ovarian cancer	0.00526	0.0914	CbGeAlD
Mexiletine—AHR—uterine cervix—ovarian cancer	0.00409	0.0712	CbGeAlD
Mexiletine—AHR—decidua—ovarian cancer	0.0039	0.0678	CbGeAlD
Mexiletine—AHR—endometrium—ovarian cancer	0.0037	0.0644	CbGeAlD
Mexiletine—AHR—uterus—ovarian cancer	0.00341	0.0593	CbGeAlD
Mexiletine—AHR—female reproductive system—ovarian cancer	0.00307	0.0533	CbGeAlD
Mexiletine—AHR—bone marrow—ovarian cancer	0.0029	0.0503	CbGeAlD
Mexiletine—AHR—female gonad—ovarian cancer	0.00279	0.0485	CbGeAlD
Mexiletine—AHR—vagina—ovarian cancer	0.00277	0.0482	CbGeAlD
Mexiletine—SCN9A—testis—ovarian cancer	0.00254	0.0441	CbGeAlD
Mexiletine—AHR—testis—ovarian cancer	0.00248	0.043	CbGeAlD
Mexiletine—SCN4A—testis—ovarian cancer	0.00226	0.0393	CbGeAlD
Mexiletine—SCN2A—vagina—ovarian cancer	0.00225	0.039	CbGeAlD
Mexiletine—SCN5A—vagina—ovarian cancer	0.00197	0.0342	CbGeAlD
Mexiletine—SCN9A—lymph node—ovarian cancer	0.00184	0.032	CbGeAlD
Mexiletine—AHR—lymph node—ovarian cancer	0.00179	0.0312	CbGeAlD
Mexiletine—SCN10A—lymph node—ovarian cancer	0.0014	0.0243	CbGeAlD
Mexiletine—CYP2B6—gonad—ovarian cancer	0.00123	0.0214	CbGeAlD
Mexiletine—Vomiting—Chlorambucil—ovarian cancer	0.0011	0.00193	CcSEcCtD
Mexiletine—Agranulocytosis—Docetaxel—ovarian cancer	0.0011	0.00193	CcSEcCtD
Mexiletine—CYP2B6—female reproductive system—ovarian cancer	0.0011	0.0191	CbGeAlD
Mexiletine—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00109	0.00192	CcSEcCtD
Mexiletine—Menopausal symptoms—Epirubicin—ovarian cancer	0.00109	0.00192	CcSEcCtD
Mexiletine—Feeling abnormal—Vinorelbine—ovarian cancer	0.00108	0.00191	CcSEcCtD
Mexiletine—Asthenia—Melphalan—ovarian cancer	0.00108	0.0019	CcSEcCtD
Mexiletine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00108	0.0019	CcSEcCtD
Mexiletine—Tension—Paclitaxel—ovarian cancer	0.00106	0.00187	CcSEcCtD
Mexiletine—Dysgeusia—Paclitaxel—ovarian cancer	0.00106	0.00187	CcSEcCtD
Mexiletine—Hepatitis—Docetaxel—ovarian cancer	0.00106	0.00186	CcSEcCtD
Mexiletine—Nervousness—Paclitaxel—ovarian cancer	0.00105	0.00186	CcSEcCtD
Mexiletine—Diarrhoea—Topotecan—ovarian cancer	0.00105	0.00185	CcSEcCtD
Mexiletine—Hypoaesthesia—Docetaxel—ovarian cancer	0.00105	0.00185	CcSEcCtD
Mexiletine—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.00105	0.00185	CcSEcCtD
Mexiletine—Pharyngitis—Docetaxel—ovarian cancer	0.00105	0.00185	CcSEcCtD
Mexiletine—Muscle spasms—Paclitaxel—ovarian cancer	0.00104	0.00184	CcSEcCtD
Mexiletine—Body temperature increased—Vinorelbine—ovarian cancer	0.00104	0.00183	CcSEcCtD
Mexiletine—Abdominal pain—Vinorelbine—ovarian cancer	0.00104	0.00183	CcSEcCtD
Mexiletine—Diarrhoea—Melphalan—ovarian cancer	0.00103	0.00181	CcSEcCtD
Mexiletine—CYP2E1—female reproductive system—ovarian cancer	0.00103	0.0179	CbGeAlD
Mexiletine—Nausea—Chlorambucil—ovarian cancer	0.00103	0.00181	CcSEcCtD
Mexiletine—Vision blurred—Paclitaxel—ovarian cancer	0.00102	0.0018	CcSEcCtD
Mexiletine—Hot flush—Doxorubicin—ovarian cancer	0.00102	0.00179	CcSEcCtD
Mexiletine—Visual impairment—Docetaxel—ovarian cancer	0.00102	0.00179	CcSEcCtD
Mexiletine—Dizziness—Topotecan—ovarian cancer	0.00102	0.00179	CcSEcCtD
Mexiletine—Tremor—Paclitaxel—ovarian cancer	0.00102	0.00179	CcSEcCtD
Mexiletine—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00101	0.00178	CcSEcCtD
Mexiletine—Menopausal symptoms—Doxorubicin—ovarian cancer	0.00101	0.00178	CcSEcCtD
Mexiletine—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00101	0.00177	CcSEcCtD
Mexiletine—Erythema multiforme—Docetaxel—ovarian cancer	0.000999	0.00176	CcSEcCtD
Mexiletine—CYP2B6—vagina—ovarian cancer	0.000993	0.0173	CbGeAlD
Mexiletine—Vomiting—Topotecan—ovarian cancer	0.000978	0.00172	CcSEcCtD
Mexiletine—Malaise—Paclitaxel—ovarian cancer	0.000978	0.00172	CcSEcCtD
Mexiletine—Syncope—Paclitaxel—ovarian cancer	0.000973	0.00171	CcSEcCtD
Mexiletine—Leukopenia—Paclitaxel—ovarian cancer	0.000971	0.00171	CcSEcCtD
Mexiletine—Rash—Topotecan—ovarian cancer	0.00097	0.00171	CcSEcCtD
Mexiletine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00097	0.00171	CcSEcCtD
Mexiletine—Dermatitis—Topotecan—ovarian cancer	0.000969	0.00171	CcSEcCtD
Mexiletine—Ataxia—Epirubicin—ovarian cancer	0.000968	0.0017	CcSEcCtD
Mexiletine—Headache—Topotecan—ovarian cancer	0.000964	0.0017	CcSEcCtD
Mexiletine—Palpitations—Paclitaxel—ovarian cancer	0.000959	0.00169	CcSEcCtD
Mexiletine—Vomiting—Melphalan—ovarian cancer	0.000958	0.00169	CcSEcCtD
Mexiletine—Loss of consciousness—Paclitaxel—ovarian cancer	0.000953	0.00168	CcSEcCtD
Mexiletine—Liver function test abnormal—Epirubicin—ovarian cancer	0.000951	0.00167	CcSEcCtD
Mexiletine—Rash—Melphalan—ovarian cancer	0.00095	0.00167	CcSEcCtD
Mexiletine—Dermatitis—Melphalan—ovarian cancer	0.000949	0.00167	CcSEcCtD
Mexiletine—Asthenia—Vinorelbine—ovarian cancer	0.000944	0.00166	CcSEcCtD
Mexiletine—Dry skin—Epirubicin—ovarian cancer	0.000944	0.00166	CcSEcCtD
Mexiletine—Arrhythmia—Docetaxel—ovarian cancer	0.000944	0.00166	CcSEcCtD
Mexiletine—Convulsion—Paclitaxel—ovarian cancer	0.00094	0.00165	CcSEcCtD
Mexiletine—Hypertension—Paclitaxel—ovarian cancer	0.000937	0.00165	CcSEcCtD
Mexiletine—Alopecia—Docetaxel—ovarian cancer	0.000933	0.00164	CcSEcCtD
Mexiletine—Arthralgia—Paclitaxel—ovarian cancer	0.000924	0.00163	CcSEcCtD
Mexiletine—Chest pain—Paclitaxel—ovarian cancer	0.000924	0.00163	CcSEcCtD
Mexiletine—Nausea—Topotecan—ovarian cancer	0.000914	0.00161	CcSEcCtD
Mexiletine—Discomfort—Paclitaxel—ovarian cancer	0.000912	0.00161	CcSEcCtD
Mexiletine—Dry mouth—Paclitaxel—ovarian cancer	0.000903	0.00159	CcSEcCtD
Mexiletine—Diarrhoea—Vinorelbine—ovarian cancer	0.000901	0.00159	CcSEcCtD
Mexiletine—Dysgeusia—Docetaxel—ovarian cancer	0.0009	0.00159	CcSEcCtD
Mexiletine—Ataxia—Doxorubicin—ovarian cancer	0.000896	0.00158	CcSEcCtD
Mexiletine—Nausea—Melphalan—ovarian cancer	0.000895	0.00158	CcSEcCtD
Mexiletine—Confusional state—Paclitaxel—ovarian cancer	0.000893	0.00157	CcSEcCtD
Mexiletine—Dysphagia—Epirubicin—ovarian cancer	0.00089	0.00157	CcSEcCtD
Mexiletine—CYP2B6—testis—ovarian cancer	0.000886	0.0154	CbGeAlD
Mexiletine—Oedema—Paclitaxel—ovarian cancer	0.000885	0.00156	CcSEcCtD
Mexiletine—Muscle spasms—Docetaxel—ovarian cancer	0.000884	0.00156	CcSEcCtD
Mexiletine—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00088	0.00155	CcSEcCtD
Mexiletine—Dry skin—Doxorubicin—ovarian cancer	0.000873	0.00154	CcSEcCtD
Mexiletine—Pancreatitis—Epirubicin—ovarian cancer	0.000873	0.00154	CcSEcCtD
Mexiletine—Shock—Paclitaxel—ovarian cancer	0.000871	0.00153	CcSEcCtD
Mexiletine—Dizziness—Vinorelbine—ovarian cancer	0.00087	0.00153	CcSEcCtD
Mexiletine—Angina pectoris—Epirubicin—ovarian cancer	0.000867	0.00153	CcSEcCtD
Mexiletine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000867	0.00153	CcSEcCtD
Mexiletine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000856	0.00151	CcSEcCtD
Mexiletine—Vomiting—Vinorelbine—ovarian cancer	0.000837	0.00147	CcSEcCtD
Mexiletine—Neutropenia—Epirubicin—ovarian cancer	0.000832	0.00147	CcSEcCtD
Mexiletine—CYP2E1—testis—ovarian cancer	0.000831	0.0144	CbGeAlD
Mexiletine—Rash—Vinorelbine—ovarian cancer	0.00083	0.00146	CcSEcCtD
Mexiletine—Dermatitis—Vinorelbine—ovarian cancer	0.000829	0.00146	CcSEcCtD
Mexiletine—CYP3A4—female reproductive system—ovarian cancer	0.000829	0.0144	CbGeAlD
Mexiletine—Hypotension—Paclitaxel—ovarian cancer	0.000827	0.00146	CcSEcCtD
Mexiletine—Headache—Vinorelbine—ovarian cancer	0.000825	0.00145	CcSEcCtD
Mexiletine—Syncope—Docetaxel—ovarian cancer	0.000825	0.00145	CcSEcCtD
Mexiletine—Dysphagia—Doxorubicin—ovarian cancer	0.000824	0.00145	CcSEcCtD
Mexiletine—Leukopenia—Docetaxel—ovarian cancer	0.000823	0.00145	CcSEcCtD
Mexiletine—CYP2D6—female reproductive system—ovarian cancer	0.000816	0.0142	CbGeAlD
Mexiletine—Palpitations—Docetaxel—ovarian cancer	0.000813	0.00143	CcSEcCtD
Mexiletine—Loss of consciousness—Docetaxel—ovarian cancer	0.000808	0.00142	CcSEcCtD
Mexiletine—Pancreatitis—Doxorubicin—ovarian cancer	0.000807	0.00142	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000807	0.00142	CcSEcCtD
Mexiletine—Angina pectoris—Doxorubicin—ovarian cancer	0.000802	0.00141	CcSEcCtD
Mexiletine—Convulsion—Docetaxel—ovarian cancer	0.000797	0.0014	CcSEcCtD
Mexiletine—Paraesthesia—Paclitaxel—ovarian cancer	0.000795	0.0014	CcSEcCtD
Mexiletine—Hypertension—Docetaxel—ovarian cancer	0.000794	0.0014	CcSEcCtD
Mexiletine—Drowsiness—Epirubicin—ovarian cancer	0.000794	0.0014	CcSEcCtD
Mexiletine—Dyspnoea—Paclitaxel—ovarian cancer	0.000789	0.00139	CcSEcCtD
Mexiletine—Somnolence—Paclitaxel—ovarian cancer	0.000787	0.00139	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000787	0.00139	CcSEcCtD
Mexiletine—Chest pain—Docetaxel—ovarian cancer	0.000783	0.00138	CcSEcCtD
Mexiletine—Arthralgia—Docetaxel—ovarian cancer	0.000783	0.00138	CcSEcCtD
Mexiletine—Nausea—Vinorelbine—ovarian cancer	0.000782	0.00138	CcSEcCtD
Mexiletine—Dyspepsia—Paclitaxel—ovarian cancer	0.000779	0.00137	CcSEcCtD
Mexiletine—Neutropenia—Doxorubicin—ovarian cancer	0.00077	0.00136	CcSEcCtD
Mexiletine—Dry mouth—Docetaxel—ovarian cancer	0.000766	0.00135	CcSEcCtD
Mexiletine—Fatigue—Paclitaxel—ovarian cancer	0.000763	0.00134	CcSEcCtD
Mexiletine—Pain—Paclitaxel—ovarian cancer	0.000757	0.00133	CcSEcCtD
Mexiletine—Constipation—Paclitaxel—ovarian cancer	0.000757	0.00133	CcSEcCtD
Mexiletine—Confusional state—Docetaxel—ovarian cancer	0.000757	0.00133	CcSEcCtD
Mexiletine—Oedema—Docetaxel—ovarian cancer	0.00075	0.00132	CcSEcCtD
Mexiletine—CYP2D6—female gonad—ovarian cancer	0.000742	0.0129	CbGeAlD
Mexiletine—Agranulocytosis—Epirubicin—ovarian cancer	0.000741	0.0013	CcSEcCtD
Mexiletine—Shock—Docetaxel—ovarian cancer	0.000738	0.0013	CcSEcCtD
Mexiletine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000735	0.00129	CcSEcCtD
Mexiletine—Drowsiness—Doxorubicin—ovarian cancer	0.000734	0.00129	CcSEcCtD
Mexiletine—Feeling abnormal—Paclitaxel—ovarian cancer	0.00073	0.00128	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000728	0.00128	CcSEcCtD
Mexiletine—Bradycardia—Epirubicin—ovarian cancer	0.000725	0.00128	CcSEcCtD
Mexiletine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000724	0.00127	CcSEcCtD
Mexiletine—Hepatitis—Epirubicin—ovarian cancer	0.000712	0.00125	CcSEcCtD
Mexiletine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000709	0.00125	CcSEcCtD
Mexiletine—Pharyngitis—Epirubicin—ovarian cancer	0.000707	0.00124	CcSEcCtD
Mexiletine—Hypotension—Docetaxel—ovarian cancer	0.000701	0.00123	CcSEcCtD
Mexiletine—Abdominal pain—Paclitaxel—ovarian cancer	0.0007	0.00123	CcSEcCtD
Mexiletine—Body temperature increased—Paclitaxel—ovarian cancer	0.0007	0.00123	CcSEcCtD
Mexiletine—Visual impairment—Epirubicin—ovarian cancer	0.000687	0.00121	CcSEcCtD
Mexiletine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000685	0.00121	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000684	0.0012	CcSEcCtD
Mexiletine—Paraesthesia—Docetaxel—ovarian cancer	0.000674	0.00119	CcSEcCtD
Mexiletine—Erythema multiforme—Epirubicin—ovarian cancer	0.000674	0.00119	CcSEcCtD
Mexiletine—Bradycardia—Doxorubicin—ovarian cancer	0.000671	0.00118	CcSEcCtD
Mexiletine—Dyspnoea—Docetaxel—ovarian cancer	0.000669	0.00118	CcSEcCtD
Mexiletine—Somnolence—Docetaxel—ovarian cancer	0.000667	0.00117	CcSEcCtD
Mexiletine—Tinnitus—Epirubicin—ovarian cancer	0.000664	0.00117	CcSEcCtD
Mexiletine—Dyspepsia—Docetaxel—ovarian cancer	0.000661	0.00116	CcSEcCtD
Mexiletine—Hepatitis—Doxorubicin—ovarian cancer	0.000659	0.00116	CcSEcCtD
Mexiletine—CYP2D6—testis—ovarian cancer	0.000658	0.0114	CbGeAlD
Mexiletine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000656	0.00115	CcSEcCtD
Mexiletine—Pharyngitis—Doxorubicin—ovarian cancer	0.000654	0.00115	CcSEcCtD
Mexiletine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000652	0.00115	CcSEcCtD
Mexiletine—Fatigue—Docetaxel—ovarian cancer	0.000647	0.00114	CcSEcCtD
Mexiletine—Pain—Docetaxel—ovarian cancer	0.000642	0.00113	CcSEcCtD
Mexiletine—Constipation—Docetaxel—ovarian cancer	0.000642	0.00113	CcSEcCtD
Mexiletine—Arrhythmia—Epirubicin—ovarian cancer	0.000636	0.00112	CcSEcCtD
Mexiletine—Visual impairment—Doxorubicin—ovarian cancer	0.000635	0.00112	CcSEcCtD
Mexiletine—Asthenia—Paclitaxel—ovarian cancer	0.000635	0.00112	CcSEcCtD
Mexiletine—Alopecia—Epirubicin—ovarian cancer	0.00063	0.00111	CcSEcCtD
Mexiletine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000623	0.0011	CcSEcCtD
Mexiletine—Feeling abnormal—Docetaxel—ovarian cancer	0.000618	0.00109	CcSEcCtD
Mexiletine—Tinnitus—Doxorubicin—ovarian cancer	0.000615	0.00108	CcSEcCtD
Mexiletine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000614	0.00108	CcSEcCtD
Mexiletine—Tension—Epirubicin—ovarian cancer	0.000609	0.00107	CcSEcCtD
Mexiletine—Dysgeusia—Epirubicin—ovarian cancer	0.000607	0.00107	CcSEcCtD
Mexiletine—Diarrhoea—Paclitaxel—ovarian cancer	0.000606	0.00107	CcSEcCtD
Mexiletine—Nervousness—Epirubicin—ovarian cancer	0.000602	0.00106	CcSEcCtD
Mexiletine—Muscle spasms—Epirubicin—ovarian cancer	0.000596	0.00105	CcSEcCtD
Mexiletine—Body temperature increased—Docetaxel—ovarian cancer	0.000593	0.00104	CcSEcCtD
Mexiletine—Abdominal pain—Docetaxel—ovarian cancer	0.000593	0.00104	CcSEcCtD
Mexiletine—Arrhythmia—Doxorubicin—ovarian cancer	0.000589	0.00104	CcSEcCtD
Mexiletine—Dizziness—Paclitaxel—ovarian cancer	0.000585	0.00103	CcSEcCtD
Mexiletine—Vision blurred—Epirubicin—ovarian cancer	0.000584	0.00103	CcSEcCtD
Mexiletine—Alopecia—Doxorubicin—ovarian cancer	0.000583	0.00103	CcSEcCtD
Mexiletine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000575	0.00101	CcSEcCtD
Mexiletine—Tension—Doxorubicin—ovarian cancer	0.000563	0.000991	CcSEcCtD
Mexiletine—Vomiting—Paclitaxel—ovarian cancer	0.000563	0.000991	CcSEcCtD
Mexiletine—Dysgeusia—Doxorubicin—ovarian cancer	0.000562	0.000989	CcSEcCtD
Mexiletine—Malaise—Epirubicin—ovarian cancer	0.000559	0.000985	CcSEcCtD
Mexiletine—Rash—Paclitaxel—ovarian cancer	0.000558	0.000983	CcSEcCtD
Mexiletine—Dermatitis—Paclitaxel—ovarian cancer	0.000558	0.000982	CcSEcCtD
Mexiletine—Nervousness—Doxorubicin—ovarian cancer	0.000557	0.000981	CcSEcCtD
Mexiletine—Syncope—Epirubicin—ovarian cancer	0.000556	0.000979	CcSEcCtD
Mexiletine—Leukopenia—Epirubicin—ovarian cancer	0.000555	0.000977	CcSEcCtD
Mexiletine—Headache—Paclitaxel—ovarian cancer	0.000555	0.000976	CcSEcCtD
Mexiletine—Hypersensitivity—Docetaxel—ovarian cancer	0.000553	0.000973	CcSEcCtD
Mexiletine—Muscle spasms—Doxorubicin—ovarian cancer	0.000552	0.000971	CcSEcCtD
Mexiletine—Palpitations—Epirubicin—ovarian cancer	0.000548	0.000965	CcSEcCtD
Mexiletine—Loss of consciousness—Epirubicin—ovarian cancer	0.000545	0.00096	CcSEcCtD
Mexiletine—Vision blurred—Doxorubicin—ovarian cancer	0.000541	0.000952	CcSEcCtD
Mexiletine—Asthenia—Docetaxel—ovarian cancer	0.000538	0.000948	CcSEcCtD
Mexiletine—Convulsion—Epirubicin—ovarian cancer	0.000537	0.000946	CcSEcCtD
Mexiletine—Hypertension—Epirubicin—ovarian cancer	0.000535	0.000943	CcSEcCtD
Mexiletine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000532	0.000937	CcSEcCtD
Mexiletine—Arthralgia—Epirubicin—ovarian cancer	0.000528	0.00093	CcSEcCtD
Mexiletine—Chest pain—Epirubicin—ovarian cancer	0.000528	0.00093	CcSEcCtD
Mexiletine—Nausea—Paclitaxel—ovarian cancer	0.000526	0.000926	CcSEcCtD
Mexiletine—Discomfort—Epirubicin—ovarian cancer	0.000522	0.000918	CcSEcCtD
Mexiletine—Malaise—Doxorubicin—ovarian cancer	0.000517	0.000911	CcSEcCtD
Mexiletine—Dry mouth—Epirubicin—ovarian cancer	0.000516	0.000909	CcSEcCtD
Mexiletine—Syncope—Doxorubicin—ovarian cancer	0.000515	0.000906	CcSEcCtD
Mexiletine—Leukopenia—Doxorubicin—ovarian cancer	0.000514	0.000904	CcSEcCtD
Mexiletine—Diarrhoea—Docetaxel—ovarian cancer	0.000513	0.000904	CcSEcCtD
Mexiletine—Confusional state—Epirubicin—ovarian cancer	0.00051	0.000899	CcSEcCtD
Mexiletine—Palpitations—Doxorubicin—ovarian cancer	0.000507	0.000893	CcSEcCtD
Mexiletine—Oedema—Epirubicin—ovarian cancer	0.000506	0.000891	CcSEcCtD
Mexiletine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000504	0.000888	CcSEcCtD
Mexiletine—Shock—Epirubicin—ovarian cancer	0.000498	0.000877	CcSEcCtD
Mexiletine—Convulsion—Doxorubicin—ovarian cancer	0.000497	0.000875	CcSEcCtD
Mexiletine—Dizziness—Docetaxel—ovarian cancer	0.000496	0.000874	CcSEcCtD
Mexiletine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000496	0.000873	CcSEcCtD
Mexiletine—Hypertension—Doxorubicin—ovarian cancer	0.000495	0.000872	CcSEcCtD
Mexiletine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000489	0.000861	CcSEcCtD
Mexiletine—Chest pain—Doxorubicin—ovarian cancer	0.000489	0.00086	CcSEcCtD
Mexiletine—Arthralgia—Doxorubicin—ovarian cancer	0.000489	0.00086	CcSEcCtD
Mexiletine—Discomfort—Doxorubicin—ovarian cancer	0.000483	0.00085	CcSEcCtD
Mexiletine—Dry mouth—Doxorubicin—ovarian cancer	0.000478	0.000841	CcSEcCtD
Mexiletine—Vomiting—Docetaxel—ovarian cancer	0.000477	0.00084	CcSEcCtD
Mexiletine—Rash—Docetaxel—ovarian cancer	0.000473	0.000833	CcSEcCtD
Mexiletine—Hypotension—Epirubicin—ovarian cancer	0.000473	0.000833	CcSEcCtD
Mexiletine—Dermatitis—Docetaxel—ovarian cancer	0.000473	0.000832	CcSEcCtD
Mexiletine—Confusional state—Doxorubicin—ovarian cancer	0.000472	0.000831	CcSEcCtD
Mexiletine—Headache—Docetaxel—ovarian cancer	0.00047	0.000828	CcSEcCtD
Mexiletine—Oedema—Doxorubicin—ovarian cancer	0.000468	0.000825	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000461	0.000812	CcSEcCtD
Mexiletine—Shock—Doxorubicin—ovarian cancer	0.000461	0.000811	CcSEcCtD
Mexiletine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000459	0.000807	CcSEcCtD
Mexiletine—Paraesthesia—Epirubicin—ovarian cancer	0.000455	0.0008	CcSEcCtD
Mexiletine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000453	0.000797	CcSEcCtD
Mexiletine—Dyspnoea—Epirubicin—ovarian cancer	0.000451	0.000794	CcSEcCtD
Mexiletine—Somnolence—Epirubicin—ovarian cancer	0.00045	0.000792	CcSEcCtD
Mexiletine—Nausea—Docetaxel—ovarian cancer	0.000446	0.000785	CcSEcCtD
Mexiletine—Dyspepsia—Epirubicin—ovarian cancer	0.000446	0.000784	CcSEcCtD
Mexiletine—Hypotension—Doxorubicin—ovarian cancer	0.000438	0.00077	CcSEcCtD
Mexiletine—Fatigue—Epirubicin—ovarian cancer	0.000436	0.000768	CcSEcCtD
Mexiletine—Pain—Epirubicin—ovarian cancer	0.000433	0.000762	CcSEcCtD
Mexiletine—Constipation—Epirubicin—ovarian cancer	0.000433	0.000762	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000427	0.000751	CcSEcCtD
Mexiletine—Paraesthesia—Doxorubicin—ovarian cancer	0.000421	0.00074	CcSEcCtD
Mexiletine—Dyspnoea—Doxorubicin—ovarian cancer	0.000418	0.000735	CcSEcCtD
Mexiletine—Feeling abnormal—Epirubicin—ovarian cancer	0.000417	0.000734	CcSEcCtD
Mexiletine—Somnolence—Doxorubicin—ovarian cancer	0.000416	0.000733	CcSEcCtD
Mexiletine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000414	0.000729	CcSEcCtD
Mexiletine—Dyspepsia—Doxorubicin—ovarian cancer	0.000412	0.000726	CcSEcCtD
Mexiletine—Fatigue—Doxorubicin—ovarian cancer	0.000404	0.000711	CcSEcCtD
Mexiletine—Pain—Doxorubicin—ovarian cancer	0.0004	0.000705	CcSEcCtD
Mexiletine—Constipation—Doxorubicin—ovarian cancer	0.0004	0.000705	CcSEcCtD
Mexiletine—Body temperature increased—Epirubicin—ovarian cancer	0.0004	0.000704	CcSEcCtD
Mexiletine—Abdominal pain—Epirubicin—ovarian cancer	0.0004	0.000704	CcSEcCtD
Mexiletine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000386	0.000679	CcSEcCtD
Mexiletine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000383	0.000674	CcSEcCtD
Mexiletine—Hypersensitivity—Epirubicin—ovarian cancer	0.000373	0.000657	CcSEcCtD
Mexiletine—Abdominal pain—Doxorubicin—ovarian cancer	0.00037	0.000652	CcSEcCtD
Mexiletine—Body temperature increased—Doxorubicin—ovarian cancer	0.00037	0.000652	CcSEcCtD
Mexiletine—Asthenia—Epirubicin—ovarian cancer	0.000363	0.000639	CcSEcCtD
Mexiletine—Diarrhoea—Epirubicin—ovarian cancer	0.000346	0.00061	CcSEcCtD
Mexiletine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000345	0.000608	CcSEcCtD
Mexiletine—Asthenia—Doxorubicin—ovarian cancer	0.000336	0.000592	CcSEcCtD
Mexiletine—Dizziness—Epirubicin—ovarian cancer	0.000335	0.000589	CcSEcCtD
Mexiletine—Vomiting—Epirubicin—ovarian cancer	0.000322	0.000567	CcSEcCtD
Mexiletine—Diarrhoea—Doxorubicin—ovarian cancer	0.00032	0.000564	CcSEcCtD
Mexiletine—Rash—Epirubicin—ovarian cancer	0.000319	0.000562	CcSEcCtD
Mexiletine—Dermatitis—Epirubicin—ovarian cancer	0.000319	0.000561	CcSEcCtD
Mexiletine—Headache—Epirubicin—ovarian cancer	0.000317	0.000558	CcSEcCtD
Mexiletine—Dizziness—Doxorubicin—ovarian cancer	0.00031	0.000545	CcSEcCtD
Mexiletine—Nausea—Epirubicin—ovarian cancer	0.000301	0.000529	CcSEcCtD
Mexiletine—Vomiting—Doxorubicin—ovarian cancer	0.000298	0.000524	CcSEcCtD
Mexiletine—Rash—Doxorubicin—ovarian cancer	0.000295	0.00052	CcSEcCtD
Mexiletine—Dermatitis—Doxorubicin—ovarian cancer	0.000295	0.000519	CcSEcCtD
Mexiletine—Headache—Doxorubicin—ovarian cancer	0.000293	0.000517	CcSEcCtD
Mexiletine—Nausea—Doxorubicin—ovarian cancer	0.000278	0.00049	CcSEcCtD
Mexiletine—SCN2A—Developmental Biology—IL6ST—ovarian cancer	0.000196	0.00153	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—IL6ST—ovarian cancer	0.000196	0.00153	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—MET—ovarian cancer	0.000193	0.00151	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000192	0.0015	CbGpPWpGaD
Mexiletine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000192	0.0015	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—MMP9—ovarian cancer	0.000191	0.0015	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—MET—ovarian cancer	0.00019	0.00149	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—IL6ST—ovarian cancer	0.000189	0.00148	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—IL6ST—ovarian cancer	0.000186	0.00146	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—MMP2—ovarian cancer	0.000182	0.00142	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—MMP9—ovarian cancer	0.000176	0.00137	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—MMP9—ovarian cancer	0.000176	0.00137	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—VEGFA—ovarian cancer	0.000172	0.00134	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—NRAS—ovarian cancer	0.00017	0.00133	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—MMP9—ovarian cancer	0.00017	0.00132	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—MMP2—ovarian cancer	0.000167	0.0013	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—MMP2—ovarian cancer	0.000167	0.0013	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—MAPK3—ovarian cancer	0.000163	0.00127	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000162	0.00126	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000162	0.00126	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—MMP2—ovarian cancer	0.000161	0.00126	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—ERBB2—ovarian cancer	0.000159	0.00124	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—MMP2—ovarian cancer	0.000159	0.00124	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.000158	0.00124	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—VEGFA—ovarian cancer	0.000158	0.00123	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—VEGFA—ovarian cancer	0.000158	0.00123	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—NRAS—ovarian cancer	0.000156	0.00122	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—NRAS—ovarian cancer	0.000156	0.00122	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—CYP1B1—ovarian cancer	0.000156	0.00122	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—MAPK1—ovarian cancer	0.000155	0.00121	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—EGFR—ovarian cancer	0.000155	0.00121	CbGpPWpGaD
Mexiletine—CYP2D6—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000154	0.0012	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—VEGFA—ovarian cancer	0.000152	0.00119	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—NRAS—ovarian cancer	0.00015	0.00118	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—MAPK3—ovarian cancer	0.000149	0.00117	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—MAPK3—ovarian cancer	0.000149	0.00117	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—ERBB2—ovarian cancer	0.000146	0.00114	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—ERBB2—ovarian cancer	0.000146	0.00114	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—KRAS—ovarian cancer	0.000146	0.00114	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—MAPK3—ovarian cancer	0.000144	0.00113	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—MAPK1—ovarian cancer	0.000142	0.00111	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—MAPK1—ovarian cancer	0.000142	0.00111	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—EGFR—ovarian cancer	0.000142	0.00111	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—EGFR—ovarian cancer	0.000142	0.00111	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—ERBB2—ovarian cancer	0.000141	0.0011	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—CTNNB1—ovarian cancer	0.000139	0.00109	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—ERBB2—ovarian cancer	0.000139	0.00109	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—MAPK1—ovarian cancer	0.000137	0.00107	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—EGFR—ovarian cancer	0.000137	0.00107	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NME2—ovarian cancer	0.000137	0.00107	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—MMP9—ovarian cancer	0.000137	0.00107	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MET—ovarian cancer	0.000136	0.00106	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000135	0.00105	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—KRAS—ovarian cancer	0.000134	0.00105	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—KRAS—ovarian cancer	0.000134	0.00105	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NME2—ovarian cancer	0.000134	0.00105	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000133	0.00104	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—IL6ST—ovarian cancer	0.000133	0.00104	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000133	0.00104	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.000132	0.00103	CbGpPWpGaD
Mexiletine—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00013	0.00102	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—KRAS—ovarian cancer	0.00013	0.00101	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—CTNNB1—ovarian cancer	0.000128	0.001	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—CTNNB1—ovarian cancer	0.000128	0.001	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—MMP9—ovarian cancer	0.000126	0.00098	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—MMP9—ovarian cancer	0.000126	0.00098	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—HRAS—ovarian cancer	0.000124	0.00097	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000124	0.000968	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—CTNNB1—ovarian cancer	0.000123	0.000964	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—VEGFA—ovarian cancer	0.000123	0.000958	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—STAT3—ovarian cancer	0.000121	0.000949	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000121	0.000947	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000121	0.000947	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000121	0.000947	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—NRAS—ovarian cancer	0.000121	0.000946	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—MMP9—ovarian cancer	0.000121	0.000945	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—MMP9—ovarian cancer	0.000119	0.000931	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—IL6—ovarian cancer	0.000119	0.000929	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—MAPK3—ovarian cancer	0.000116	0.000906	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000114	0.000894	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—HRAS—ovarian cancer	0.000114	0.000892	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—HRAS—ovarian cancer	0.000114	0.000892	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MMP2—ovarian cancer	0.000113	0.000884	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—VEGFA—ovarian cancer	0.000113	0.00088	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—VEGFA—ovarian cancer	0.000113	0.00088	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—STAT3—ovarian cancer	0.000112	0.000872	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—STAT3—ovarian cancer	0.000112	0.000872	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—NRAS—ovarian cancer	0.000111	0.00087	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—NRAS—ovarian cancer	0.000111	0.00087	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—MAPK1—ovarian cancer	0.00011	0.000862	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—EGFR—ovarian cancer	0.00011	0.000862	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—HRAS—ovarian cancer	0.00011	0.00086	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—IL6—ovarian cancer	0.000109	0.000853	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—IL6—ovarian cancer	0.000109	0.000853	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—VEGFA—ovarian cancer	0.000109	0.000849	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—STAT3—ovarian cancer	0.000108	0.000841	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—NRAS—ovarian cancer	0.000107	0.000839	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—VEGFA—ovarian cancer	0.000107	0.000836	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—MAPK3—ovarian cancer	0.000107	0.000833	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—MAPK3—ovarian cancer	0.000107	0.000833	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—NRAS—ovarian cancer	0.000106	0.000826	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—IL6—ovarian cancer	0.000105	0.000823	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—KRAS—ovarian cancer	0.000104	0.000814	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—MAPK3—ovarian cancer	0.000103	0.000803	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000102	0.000796	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000102	0.000795	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—MAPK1—ovarian cancer	0.000101	0.000792	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—MAPK1—ovarian cancer	0.000101	0.000792	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—EGFR—ovarian cancer	0.000101	0.000792	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—EGFR—ovarian cancer	0.000101	0.000792	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—MAPK3—ovarian cancer	0.000101	0.000791	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000101	0.000785	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—ERBB2—ovarian cancer	9.92e-05	0.000775	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—MAPK1—ovarian cancer	9.78e-05	0.000764	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—EGFR—ovarian cancer	9.78e-05	0.000764	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	9.73e-05	0.00076	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—MAPK1—ovarian cancer	9.64e-05	0.000753	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—EGFR—ovarian cancer	9.64e-05	0.000753	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—KRAS—ovarian cancer	9.58e-05	0.000748	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—KRAS—ovarian cancer	9.58e-05	0.000748	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NME2—ovarian cancer	9.51e-05	0.000742	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—KRAS—ovarian cancer	9.24e-05	0.000722	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—KRAS—ovarian cancer	9.1e-05	0.000711	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—HRAS—ovarian cancer	8.86e-05	0.000692	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYTB—ovarian cancer	8.81e-05	0.000688	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—CTNNB1—ovarian cancer	8.68e-05	0.000678	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYTB—ovarian cancer	8.63e-05	0.000674	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MMP9—ovarian cancer	8.51e-05	0.000665	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—IL6—ovarian cancer	8.48e-05	0.000663	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—HRAS—ovarian cancer	8.15e-05	0.000636	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—HRAS—ovarian cancer	8.15e-05	0.000636	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NME2—ovarian cancer	8.05e-05	0.000629	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—HRAS—ovarian cancer	7.86e-05	0.000613	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—AKT1—ovarian cancer	7.83e-05	0.000611	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—IL6—ovarian cancer	7.8e-05	0.000609	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—IL6—ovarian cancer	7.8e-05	0.000609	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—HRAS—ovarian cancer	7.74e-05	0.000604	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PPP1CC—ovarian cancer	7.7e-05	0.000602	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—BRIP1—ovarian cancer	7.7e-05	0.000602	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—VEGFA—ovarian cancer	7.64e-05	0.000597	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—STAT3—ovarian cancer	7.57e-05	0.000591	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—NRAS—ovarian cancer	7.55e-05	0.00059	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PPP1CC—ovarian cancer	7.55e-05	0.000589	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—BRIP1—ovarian cancer	7.55e-05	0.000589	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—IL6—ovarian cancer	7.52e-05	0.000587	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—IL6—ovarian cancer	7.41e-05	0.000578	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MAPK3—ovarian cancer	7.23e-05	0.000565	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—AKT1—ovarian cancer	7.19e-05	0.000562	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—AKT1—ovarian cancer	7.19e-05	0.000562	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—AKT1—ovarian cancer	6.94e-05	0.000542	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MAPK1—ovarian cancer	6.88e-05	0.000537	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—EGFR—ovarian cancer	6.88e-05	0.000537	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.83e-05	0.000533	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—KRAS—ovarian cancer	6.5e-05	0.000507	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NME2—ovarian cancer	6.22e-05	0.000485	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYTB—ovarian cancer	6.13e-05	0.000478	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.57e-05	0.000435	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—HRAS—ovarian cancer	5.52e-05	0.000431	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PPP1CC—ovarian cancer	5.35e-05	0.000418	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—BRIP1—ovarian cancer	5.35e-05	0.000418	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—IL6—ovarian cancer	5.29e-05	0.000413	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYTB—ovarian cancer	5.19e-05	0.000405	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—YAP1—ovarian cancer	5.17e-05	0.000404	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.07e-05	0.000396	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—YAP1—ovarian cancer	5.06e-05	0.000395	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—AKT1—ovarian cancer	4.88e-05	0.000381	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—BRIP1—ovarian cancer	4.54e-05	0.000354	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PPP1CC—ovarian cancer	4.54e-05	0.000354	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—FASN—ovarian cancer	4.21e-05	0.000329	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—SLC5A5—ovarian cancer	4.14e-05	0.000324	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—FASN—ovarian cancer	4.13e-05	0.000322	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—SLC5A5—ovarian cancer	4.06e-05	0.000317	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYTB—ovarian cancer	4e-05	0.000313	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—SLC2A1—ovarian cancer	4e-05	0.000312	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—SLC2A1—ovarian cancer	3.92e-05	0.000306	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP1B1—ovarian cancer	3.84e-05	0.0003	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP1B1—ovarian cancer	3.76e-05	0.000293	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—YAP1—ovarian cancer	3.59e-05	0.00028	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—BRIP1—ovarian cancer	3.5e-05	0.000273	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	3.5e-05	0.000273	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	3.4e-05	0.000266	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	3.33e-05	0.00026	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.31e-05	0.000258	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ABCB1—ovarian cancer	3.16e-05	0.000247	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—TYMS—ovarian cancer	3.1e-05	0.000242	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ABCB1—ovarian cancer	3.09e-05	0.000242	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—YAP1—ovarian cancer	3.04e-05	0.000238	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—TYMS—ovarian cancer	3.04e-05	0.000237	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.01e-05	0.000235	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—FASN—ovarian cancer	2.93e-05	0.000229	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	2.88e-05	0.000225	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	2.78e-05	0.000217	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	2.67e-05	0.000208	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.65e-05	0.000207	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CAV1—ovarian cancer	2.5e-05	0.000195	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—FASN—ovarian cancer	2.48e-05	0.000194	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CAV1—ovarian cancer	2.45e-05	0.000191	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SLC5A5—ovarian cancer	2.44e-05	0.000191	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	2.36e-05	0.000185	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SLC2A1—ovarian cancer	2.36e-05	0.000184	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—YAP1—ovarian cancer	2.35e-05	0.000183	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.31e-05	0.00018	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CG—ovarian cancer	2.28e-05	0.000178	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP1B1—ovarian cancer	2.26e-05	0.000176	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CG—ovarian cancer	2.23e-05	0.000174	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ABCB1—ovarian cancer	2.2e-05	0.000171	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—TYMS—ovarian cancer	2.16e-05	0.000168	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	2e-05	0.000156	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CD—ovarian cancer	2e-05	0.000156	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.99e-05	0.000156	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CD—ovarian cancer	1.96e-05	0.000153	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—FASN—ovarian cancer	1.91e-05	0.000149	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.88e-05	0.000147	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ABCB1—ovarian cancer	1.86e-05	0.000145	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—TYMS—ovarian cancer	1.83e-05	0.000143	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.82e-05	0.000142	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CB—ovarian cancer	1.74e-05	0.000136	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.74e-05	0.000136	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CAV1—ovarian cancer	1.74e-05	0.000136	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CB—ovarian cancer	1.71e-05	0.000133	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	1.58e-05	0.000124	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.55e-05	0.000121	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PTEN—ovarian cancer	1.51e-05	0.000118	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PTEN—ovarian cancer	1.48e-05	0.000115	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CAV1—ovarian cancer	1.47e-05	0.000115	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.44e-05	0.000112	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—TYMS—ovarian cancer	1.41e-05	0.00011	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.41e-05	0.00011	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	1.39e-05	0.000109	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.34e-05	0.000105	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	1.21e-05	9.47e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.18e-05	9.21e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CAV1—ovarian cancer	1.14e-05	8.87e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	1.06e-05	8.31e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PTEN—ovarian cancer	1.05e-05	8.18e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.04e-05	8.14e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.03e-05	8.08e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.03e-05	8.02e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	9.1e-06	7.1e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PTEN—ovarian cancer	8.88e-06	6.93e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—AKT1—ovarian cancer	8.69e-06	6.79e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—AKT1—ovarian cancer	8.51e-06	6.65e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	7.93e-06	6.19e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	7.39e-06	5.77e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PTEN—ovarian cancer	6.85e-06	5.35e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	6.26e-06	4.89e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—AKT1—ovarian cancer	6.04e-06	4.72e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—AKT1—ovarian cancer	5.12e-06	4e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	4.83e-06	3.77e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—AKT1—ovarian cancer	3.95e-06	3.08e-05	CbGpPWpGaD
